Lexaria Bioscience (LEXX) Earnings Date, Estimates & Call Transcripts $1.73 -0.02 (-1.14%) As of 03:35 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Lexaria Bioscience Latest Earnings SummaryUpcoming Q2 Earnings DateApr. 8Before Market OpensEstimatedActual EPS (Jan. 10) -$0.16 Missed By -$0.04 Consensus EPS (Jan. 10) -$0.12 Lexaria Bioscience posted Q1 2025 earnings on January 10, 2025, reporting an EPS of -$0.16, which missed the consensus estimate of -$0.12 by $0.04. With a trailing EPS of -$0.50, Lexaria Bioscience's earnings are expected to grow next year, from ($0.59) to ($0.46) per share. LEXX Upcoming EarningsLexaria Bioscience's next earnings date is estimated for Tuesday, April 8, 2025, based off prior year's reporting schedules. Get Lexaria Bioscience Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Lexaria Bioscience and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataLEXX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.LEXX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads Lexaria Bioscience Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.12-$0.12-$0.12Q2 20252-$0.14-$0.11-$0.13Q3 20252-$0.14-$0.11-$0.13Q4 20252-$0.13-$0.11-$0.12FY 20257($0.53)($0.45)($0.49) Remove Ads Lexaria Bioscience Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 4/8/2025(Estimated)-------1/10/2025Q1 2025-$0.12-$0.16 -$0.04-$0.16--11/26/2024Q4 2024-$0.11-$0.15 -$0.04-$0.15--7/12/2024Q3 2024-$0.09-$0.13 -$0.04-$0.13$0.15M$0.08M4/9/2024Q2 2024--$0.06 -$0.06-$0.06-$0.15M1/12/2024Q1 2024--$0.13 -$0.13-$0.13-$0.15M11/21/2023Q4 2023-$0.17-$0.12+$0.05-$0.12--7/14/2023Q3 2023-$0.25-$0.37 -$0.12-$0.37$0.08M$0.09M4/14/2023Q2 2023--$0.22 -$0.22-$0.22-$0.04M Lexaria Bioscience Earnings - Frequently Asked Questions When is Lexaria Bioscience's earnings date? Lexaria Bioscience has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, April 8th, 2025 based off last year's report dates. Learn more on LEXX's earnings history. Did Lexaria Bioscience beat their earnings estimates last quarter? In the previous quarter, Lexaria Bioscience (NASDAQ:LEXX) missed the analysts' consensus estimate of ($0.12) by $0.04 with a reported earnings per share (EPS) of ($0.16). Learn more on analysts' earnings estimate vs. LEXX's actual earnings. How much revenue does Lexaria Bioscience generate each year? Lexaria Bioscience (NASDAQ:LEXX) has a recorded annual revenue of $496,923.00. How much profit does Lexaria Bioscience generate each year? Lexaria Bioscience (NASDAQ:LEXX) has a recorded net income of -$5.80 million. LEXX has generated -$0.50 earnings per share over the last four quarters. What is Lexaria Bioscience's EPS forecast for next year? Lexaria Bioscience's earnings are expected to grow from ($0.59) per share to ($0.46) per share in the next year. More Earnings Resources from MarketBeat Related Companies Lexeo Therapeutics Earnings Results Immunic Earnings Results TuHURA Biosciences Earnings Results Galectin Therapeutics Earnings Results Ventyx Biosciences Earnings Results DBV Technologies Earnings Results Adverum Biotechnologies Earnings Results Anixa Biosciences Earnings Results Black Diamond Therapeutics Earnings Results Cardiol Therapeutics Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Intuitive Machines Gains After Earnings Beat, NASA Missions AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside?These 3 Q1 Earnings Winners Will Go HigherWhat Is the Price-to-Earnings (P/E) Ratio?Analysts Lift Archer Aviation Stock Despite Earnings Miss Remove Ads This page (NASDAQ:LEXX) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lexaria Bioscience Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lexaria Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LEXX Stock Free LEXX Stock Alerts